Medtronic plc

# Signal Note: Eventide Initiates MDT Position Eventide's $10.8M entry into Medtronic signals confidence in the diversified medtech portfolio ahead of potential procedural volume recovery and margin expansion. The position likely reflects conviction in MDT's core cardio/neuro franchises and recent M&A integration (e.g., Intersect ENT), though values-aligned investors typically target the company's medical device safety track record and governance practices over specific near-term catalysts.